Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate [...]
Unable to ‘align’ with FDA, Regeneron, Sanofi pull application for Libtayo in cervical cancer days before decision date
Unable to ‘align’ with FDA, Regeneron, Sanofi pull application for [...]
Fierce Pharma Asia—Samsung Biologics’ mRNA ambition, GSK COVID-19 vaccine supply; Fujifilm’s plant buy
Fierce Pharma Asia—Samsung Biologics’ mRNA ambition, GSK COVID-19 vaccine supply; [...]
Eli Lilly, with Alzheimer’s top of mind, plots 300 jobs at new $445M manufacturing plant
Eli Lilly, with Alzheimer’s top of mind, plots 300 jobs [...]
UPDATED: Eli Lilly to plow a total of $1.5B into 2 new manufacturing plants
UPDATED: Eli Lilly to plow a total of $1.5B into [...]
Samsung buys Biogen out of biosimilar unit for $2.3B—not the whole Aduhelm headache
Samsung buys Biogen out of biosimilar unit for $2.3B—not the [...]
Pfizer in Texas showdown: Court hearing this week will decide if it can assist FDA in providing COVID documents
Pfizer in Texas showdown: Court hearing this week will decide [...]
FDA slaps Aurobindo with warning letter on API testing failures, repeated violations
FDA slaps Aurobindo with warning letter on API testing failures, [...]
Novo Nordisk’s Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts
Novo Nordisk’s Wegovy, hamstrung by Catalent FDA write-up, could correct [...]
What competition? Vertex touts Trikafta’s competitive edge on back of strong 2021
What competition? Vertex touts Trikafta’s competitive edge on back of [...]